EXPERIENCES WITH MARSILID WITH REPORT OF ONE DEATH
Abstract
Marsilid has proven to our satisfaction that it is the most effective chemical to appear so far for the treatment of ambulatory depressions. Its action is physiological. We do not know its effectiveness for patients severely depressed enough to require hospitalization. Several of our patients did not require ECT, which we would otherwise have prescribed. The drug is apparently toxic to a dangerous degree to certain individuals, and toxic to very mild degrees in others. Perhaps it is a safe drug to use for a limited period. It is unclear whether total dosage, duration of treatment, or purely idiosyncracity are related to these hepatitis reactions. This is an important therapeutic advance which should be pursued further, but a safe regimen needs to be worked out as more data are accumulated.
Access content
To read the fulltext, please use one of the options below to sign in or purchase access.- Personal login
- Institutional Login
- Sign in via OpenAthens
- Register for access
-
Please login/register if you wish to pair your device and check access availability.
Not a subscriber?
PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.
Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).
